547 related articles for article (PubMed ID: 17539249)
1. Lipid profiles of Thai adult HIV-infected patients receiving protease inhibitors.
Hiransuthikul N; Hiransuthikul P; Kanasook Y
Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):69-77. PubMed ID: 17539249
[TBL] [Abstract][Full Text] [Related]
2. Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?
Fontas E; van Leth F; Sabin CA; Friis-Møller N; Rickenbach M; d'Arminio Monforte A; Kirk O; Dupon M; Morfeldt L; Mateu S; Petoumenos K; El-Sadr W; de Wit S; Lundgren JD; Pradier C; Reiss P;
J Infect Dis; 2004 Mar; 189(6):1056-74. PubMed ID: 14999610
[TBL] [Abstract][Full Text] [Related]
3. Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.
Nguyen ST; Eaton SA; Bain AM; Rahman AP; Payne KD; Bedimo R; Herrington JD; Maclayton DO; Rodriguez-Barradas MC; Busti AJ
Pharmacotherapy; 2008 Mar; 28(3):323-30. PubMed ID: 18294112
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in triglyceride-rich lipoproteins.
Rimland D; Guest JL; Hernández I; Del Rio C; Le NA; Brown WV
HIV Med; 2005 Sep; 6(5):326-33. PubMed ID: 16156880
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of dyslipidemia in the Iraqi adult population.
Mula-Abed WA; Chilmeran SK
Saudi Med J; 2007 Dec; 28(12):1868-74. PubMed ID: 18060219
[TBL] [Abstract][Full Text] [Related]
6. Dyslipidaemia and insulin resistance in vertically HIV-infected children and adolescents.
dos Reis LC; de Carvalho Rondó PH; de Sousa Marques HH; de Andrade SB
Trans R Soc Trop Med Hyg; 2011 Apr; 105(4):197-203. PubMed ID: 21371728
[TBL] [Abstract][Full Text] [Related]
7. Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study.
Young J; Weber R; Rickenbach M; Furrer H; Bernasconi E; Hirschel B; Tarr PE; Vernazza P; Battegay M; Bucher HC
Antivir Ther; 2005; 10(5):585-91. PubMed ID: 16152752
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy.
Riddler SA; Li X; Chu H; Kingsley LA; Dobs A; Evans R; Palella F; Visscher B; Chmiel JS; Sharrett A
HIV Med; 2007 Jul; 8(5):280-7. PubMed ID: 17561873
[TBL] [Abstract][Full Text] [Related]
9. Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir.
Llibre JM; Domingo P; Palacios R; Santos J; Pérez-Elías MJ; Sánchez-de la Rosa R; Miralles C; Antela A; Moreno S;
AIDS; 2006 Jun; 20(10):1407-14. PubMed ID: 16791015
[TBL] [Abstract][Full Text] [Related]
10. Rural-urban difference in lipid levels and prevalence of dyslipidemia: a population-based study in Khon Kaen province, Thailand.
Pongchaiyakul C; Hongsprabhas P; Pisprasert V; Pongchaiyakul C
J Med Assoc Thai; 2006 Nov; 89(11):1835-44. PubMed ID: 17205863
[TBL] [Abstract][Full Text] [Related]
11. HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment.
Rose H; Woolley I; Hoy J; Dart A; Bryant B; Mijch A; Sviridov D
Metabolism; 2006 Jan; 55(1):90-5. PubMed ID: 16324925
[TBL] [Abstract][Full Text] [Related]
12. Serum lipid profiles including non-high density lipoprotein cholesterol levels in Turkish school-children.
Uçar B; Kiliç Z; Dinleyici EC; Colak O; Güneş E
Anadolu Kardiyol Derg; 2007 Dec; 7(4):415-20. PubMed ID: 18065339
[TBL] [Abstract][Full Text] [Related]
13. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
Bersot TP; Pépin GM; Mahley RW
Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
[TBL] [Abstract][Full Text] [Related]
14. Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins.
Negredo E; Moltó J; Puig J; Cinquegrana D; Bonjoch A; Pérez-Alvarez N; López-Blázquez R; Blanco A; Clotet B; Rey-Joly C
AIDS; 2006 Nov; 20(17):2159-64. PubMed ID: 17086055
[TBL] [Abstract][Full Text] [Related]
15. Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women.
Floris-Moore M; Howard AA; Lo Y; Arnsten JH; Santoro N; Schoenbaum EE
HIV Med; 2006 Oct; 7(7):421-30. PubMed ID: 16925727
[TBL] [Abstract][Full Text] [Related]
16. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in the lipid profile of dyslipidemic subjects.
Kolovou GD; Anagnostopoulou KK; Damaskos DS; Bilianou HI; Mihas C; Milionis HJ; Kostakou PM; Cokkinos DV
Eur J Intern Med; 2009 Mar; 20(2):145-51. PubMed ID: 19327602
[TBL] [Abstract][Full Text] [Related]
18. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
Skwarek M; Bilińska ZT; Mazurkiewicz Ł; Grzybowski J; Kruk M; Kurjata P; Piotrowski W; Ruzyłło W
Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
[TBL] [Abstract][Full Text] [Related]
19. Lipid profile changes in Thai HIV and tuberculosis co-infected patients receiving non-nucleoside reverse transcriptase inhibitors-based antiretroviral therapy.
Mankhatitham W; Luaengniyomkul A; Manosuthi W
J Med Assoc Thai; 2012 Feb; 95(2):163-9. PubMed ID: 22435244
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and risk factors of hypercholesterolemia among Thai men and women receiving health examinations.
Le D; Garcia A; Lohsoonthorn V; Williams MA
Southeast Asian J Trop Med Public Health; 2006 Sep; 37(5):1005-14. PubMed ID: 17333747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]